Comparison of Quantitative and Semiquantitative Enzyme-Linked Immunosorbent Assays for Immunoglobulin G against Chlamydophila pneumoniae to a Microimmunofluorescence Test for Use with Patients with Respiratory Tract Infections
Open Access
- 1 June 2004
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 42 (6) , 2476-9
- https://doi.org/10.1128/jcm.42.6.2476-2479.2004
Abstract
We previously reported a high degree of variation in the sensitivities of serodiagnostic kits for the detection of Chlamydophila pneumoniae in sera from healthy donors. Since a low predictive value of a test can impair its diagnostic value, we have extended our studies to samples from patients with pneumonia. We focused on the most promising enzyme-linked immunosorbent assays (ELISAs) (SeroCP and SeroCP Quant; Savyon) identified in our previous study and included a new ELISA (sELISA; Medac). The agreement between all ELISAs for immunoglobulin G (IgG) and a reference microimmunofluorescence (MIF) test for IgG (SeroFIA; Savyon) was ≥90% for a collective of 80 patients. The positive predictive values were all ≥93%. The negative predictive values ranged from 68 to 83%. False-negative results were obtained only for samples that had low titers in the MIF test. The correlation of the IgG antibody titers determined by the MIF and SeroCP Quant tests was high ( r sp = 0.9). Since the semiquantitative SeroCP and quantitative SeroCP Quant ELISAs achieved the highest sensitivities, they were evaluated further by using a second batch of sera from 50 patients with predominantly medium and low antibody titers in the MIF test and a control collection of sera from 80 children with negative MIF results. Again, the tests showed a high concordance with the MIF results (96%), and the antibody titers in the SeroCP Quant and MIF tests correlated well ( r sp = 0.8). The specificities determined with the negative sera were ≥99% for the SeroCP Quant test and 86% for the SeroCP test. These results show that ELISAs that are fast and objective deliver seroprevalence results, sensitivities, and specificities that are very similar to those of the MIF test.Keywords
This publication has 32 references indexed in Scilit:
- Performance of Three Microimmunofluorescence Assays for Detection of Chlamydia pneumoniae Immunoglobulin M, G, and A AntibodiesClinical and Vaccine Immunology, 2002
- Comparison of Eleven Commercial Tests for Chlamydia pneumoniae -Specific Immunoglobulin G in Asymptomatic Healthy IndividualsJournal of Clinical Microbiology, 2002
- Role of persistent infection in the control and severity of asthma: focus onChlamydia pneumoniaeEuropean Respiratory Journal, 2002
- Effect of Prolonged Treatment with Azithromycin, Clarithromycin, or Levofloxacin onChlamydia pneumoniaein a Continuous-Infection ModelAntimicrobial Agents and Chemotherapy, 2002
- StandardizingChlamydia pneumoniaeAssays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada)Clinical Infectious Diseases, 2001
- Replicate PCR Testing and Probit Analysis for Detection and Quantitation of Chlamydia pneumoniae in Clinical SpecimensJournal of Clinical Microbiology, 2001
- Chlamydia pneumoniaeSerology: Interlaboratory Variation in Microimmunofluorescence Assay ResultsThe Journal of Infectious Diseases, 2000
- Temperature-controlled radiofrequency catheter ablation of AV conduction: first clinical experienceEuropean Heart Journal, 1993
- Specificity of the microimmunofluorescence assay for the serodiagnosis of Chlamydia pneumoniae infectionsCanadian Journal of Microbiology, 1992
- A New Respiratory Tract Pathogen: Chlamydia pneumoniae Strain TWARThe Journal of Infectious Diseases, 1990